Neuronal Nicotinic Receptors as New Targets for Amphetamine-Induced Oxidative Damage and Neurotoxicity
Open Access
- 15 June 2011
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 4 (6), 822-847
- https://doi.org/10.3390/ph4060822
Abstract
Amphetamine derivatives such as methamphetamine (METH) and 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) are widely abused drugs in a recreational context. This has led to concern because of the evidence that they are neurotoxic in animal models and cognitive impairments have been described in heavy abusers. The main targets of these drugs are plasmalemmal and vesicular monoamine transporters, leading to reverse transport and increased monoamine efflux to the synapse. As far as neurotoxicity is concerned, increased reactive oxygen species (ROS) production seems to be one of the main causes. Recent research has demonstrated that blockade of a7 nicotinic acetylcholine receptors (nAChR) inhibits METH- and MDMA-induced ROS production in striatal synaptosomes which is dependent on calcium and on NO-synthase activation. Moreover, a7 nAChR antagonists (methyllycaconitine and memantine) attenuated in vivo the neurotoxicity induced by METH and MDMA, and memantine prevented the cognitive impairment induced by these drugs. Radioligand binding experiments demonstrated that both drugs have affinity to a7 and heteromeric nAChR, with MDMA showing lower Ki values, while fluorescence calcium experiments indicated that MDMA behaves as a partial agonist on a7 and as an antagonist on heteromeric nAChR. Sustained Ca increase led to calpain and caspase-3 activation. In addition, modulatory effects of MDMA on a7 and heteromeric nAChR populations have been found.This publication has 129 references indexed in Scilit:
- Regulation of Glutamate Release by α7 Nicotinic Receptors: Differential Role in Methamphetamine-Induced Damage to Dopaminergic and Serotonergic TerminalsThe Journal of pharmacology and experimental therapeutics, 2010
- The effects of 3,4-methylenedioxymethamphetamine (MDMA) on nicotinic receptors: Intracellular calcium increase, calpain/caspase 3 activation, and functional upregulationToxicology and Applied Pharmacology, 2010
- Methamphetamine toxicity and messengers of deathBrain Research Reviews, 2009
- Memantine protects against amphetamine derivatives-induced neurotoxic damage in rodentsNeuropharmacology, 2008
- Different oxidative profile and nicotinic receptor interaction of amphetamine and 3,4-methylenedioxy-methamphetamineNeurochemistry International, 2008
- Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulationBiochemical Pharmacology, 2007
- Neuronal nitric oxide synthase and the serotonin transporter get harmoniousProceedings of the National Academy of Sciences of the United States of America, 2007
- Nicotine addiction and comorbidity with alcohol abuse and mental illnessNature Neuroscience, 2005
- Effect of memantine on the ?7 neuronal nicotinic receptors, synaptophysin- and low molecular weight MAP-2 levels in the brain of transgenic mice over-expressing human acetylcholinesteraseJournal of Neural Transmission, 2004
- Oxidation of vitamin E and vitamin C and inhibition of brain mitochondrial oxidative phosphorylation by peroxynitriteJournal of Neuroscience Research, 2004